(Q33460962)

English

Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

light coagulation

1 reference

based on heuristic

inferred from title

neovascularization

1 reference

based on heuristic

inferred from title

author name string

D P Han

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J T McAllister

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

D V Weinberg

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

J E Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

W J Wirostko

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

publication date

5 June 2009

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

713-716

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Visual loss after successful photocoagulation of choroidal neovascularization

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.122

21 January 2018

Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.122

21 January 2018

Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration: year 1 results of the FOCUS Study.

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.122

21 January 2018

Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.122

7 January 2021

based on heuristic

inferred from DOI database lookup

Laser photocoagulation for choroidal neovascularisation in pathologic myopia

1 reference

https://api.crossref.org/works/10.1038%2FEYE.2009.122

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/EYE.2009.122

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33460962&oldid=2195385387"